 WATERTOWN, Mass., Dec. 16, 2022 GLOBE NEWSWIRE EyePoint Pharmaceuticals, Inc. NASDAQ: EYPT, a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced that the Company granted non-statutory stock options to a new employee as an inducement award outside the Companys 2016 Long-Term ... The post EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635c4 appear... 